Dr. Suchi Pandey, SBC's newest Medical Director

Dr. Suchi Pandey

Dr. Suchi Pandey is originally from the Philadelphia area and received an MD from Drexel University College of Medicine in Philadelphia. She did her residency in anatomic and clinical pathology at the University of California, San Diego and completed a one-year transfusion medicine fellowship at the University of California, San Francisco and Blood Centers of the Pacific. She is board-certified in anatomic and clinical pathology and in transfusion medicine.

Before joining the Stanford Blood Center team, Dr. Pandey spent eight years as the Medical Director/Chief Medical Officer at Blood Centers of the Pacific in San Francisco and two years as an Assistant Medical Director in the UCSF Transfusion Service. In these positions, she gained invaluable experience working in a large community blood center and a complex hospital transfusion service.

Dr. Pandey is currently the Chief Medical Officer for Stanford Blood Center and a Clinical Professor in the Department of Pathology at Stanford University’s School of Medicine. She provides medical oversight and direction to the Stanford Blood Center and is an attending physician in the Transfusion Service at Stanford Health Care and Lucile Packard Children’s Hospital. Her responsibilities include management of blood donor medical issues, development of Blood Center policy, consultation on patients requiring transfusion and apheresis, and the teaching/supervision of fellows and residents. She is currently also one of the Blood Center’s CLIA Lab Directors.

Dr. Pandey’s interests include donor health, transfusion medicine education, cell therapy, leukapheresis, and expanding the Blood Center’s role in research and public health initiatives. Dr Pandey is a principal investigator for research protocols performed at the blood center and recently led a project with the California Department of Public Health to implement source plasma collections at the Blood Center for the manufacture of BabyBIG®, the only FDA approved medication to treat infant botulism.

Dr. Pandey is actively involved in the transfusion medicine community and currently serves as an industry representative on FDA’s Blood Product Advisory Committee (BPAC). Additionally, she is an active member on multiple Association for the Advancement of Blood & Biotherapies (AABB) Committees, including the Transfusion Transmitted Disease Committee and the Donor History Task Force Committee. She also participates in America’s Blood Centers (ABC) Scientific/Medical Committee and Blood Centers of America’s Advance Therapies Committee.

Outside of work, Dr. Pandey enjoys the outdoors, gardening and exploring all the Bay Area has to offer with her family and friends. She loves international travel and tries to visit a few different countries every year. She also enjoys music and going to concerts. She plays violin and is learning to play the guitar.